Top Stock Movers Nov 19, 2026: Why LVWR, SEAT, MRKR Surged
The biggest stock gainers at the Nov 19, 2026 close: LVWR, SEAT, MRKR, POAS and GNLN. What drove each move, and the risks of chasing them.
LVWR — LiveWire Group, Inc. (+73.3%)
LiveWire Group closed up 73.3% at $0.64 on 52.5 million shares, about 16 times its 20-day average of 3.3 million. Market cap is only $76.9M.
No news, filing or announcement explains the jump. The recent headlines are bearish: on Nov. 17 the company filed an 8-K about NYSE delisting of its warrants (the $11.50 exercise-price warrants). The common stock stays listed. Coverage also mentions a going-concern warning. So this looks momentum-driven, not fundamentally driven.
The setup is a squeeze-style one. Free float is just 4.8%. Low float means few shares are available to trade, so price can swing violently on heavy demand. Short-volume was 51% of the day's volume. Short-volume is the share of trades that were short sales, and it is not the same as short interest.
The technical picture is weak despite the pop. A bullish engulfing candle printed, but RSI is 42, the moving-average stack is bearish, and the stock is 87.5% below its 52-week high. Conviction is 40/100 (grade D), relative strength rating is 4, and the trend-template score is 1. The stock gapped down 1.3% at the open, so the entire rally happened intraday.
SEAT — Vivid Seats Inc. (+63.3%)
Vivid Seats closed up 63.3% at $2.09 on 17.2 million shares, versus a 20-day average of about 994,000. It gapped up 94.5% at the open. That is a gap, meaning the open was far above the prior close. See our premarket recap for the morning move.
The catalyst was a debt recapitalization announced Nov. 19. Vivid Seats said it signed a transaction support agreement with an ad hoc group of lenders holding a substantial majority of its term loans. Per Benzinga, the shares were up 93% intraday at $2.47. Per the company's announcement as summarized by Quiver Quantitative, about $273 million of secured debt would be swapped for roughly 45.8 million new Class A shares. The company says net debt would fall by about $232 million. Closing is expected around January 2027, and the deal could terminate if it has not closed by Jan. 31, 2027.
The catch is dilution. Summaries say existing holders would fall to about 20% of common equity. These terms come from secondary summaries, so check them against the primary SEC filing. The stock gave back part of its intraday peak by the close.
Technically, RSI is 47, the MA stack is bearish and the stock sits 79.7% below its 52-week high. Conviction is 40/100 (grade D), RS rating 6, trend-template 1. Free float is 49.2% and short-volume was 59%. Market cap is $14.6M.
MRKR — Marker Therapeutics, Inc. (+54.7%)
Marker Therapeutics closed up 54.7% at $1.32 on 58.5 million shares, about 19 times its 20-day average of 3.0 million. Market cap is $14.2M. It gapped up 18.4% at the open.
The most likely catalyst is a $16.2 million grant from the Cancer Prevention and Research Institute of Texas (CPRIT), reported Nov. 19, to advance its investigational therapy MT-601 into a Phase 2 trial. The company also filed an 8-K dated that day. No source directly ties the grant to the size of the move, so that link is an inference. Earlier this week (Nov. 16) the company reported a Q3 loss and missed revenue estimates, and coverage noted its funding runway has a limit.
Technically, a three inside up candle (a bullish reversal pattern) formed. RSI is 68, ADX is 20 (a weak trend), and the MA stack is mixed. The stock is 46.3% below its 52-week high. RS rating is strong at 86 and technical rank 78, but conviction is only 4/100 (grade D) and trend-template is 4.
Free float is 77.5% and short-volume was 29%, so this is not a classic low-float squeeze. Small biotechs often fund themselves by selling shares after good news, which can pressure the price.
POAS — PHAOS TECHNOLOGY HOLDINGS (CAYMAN) Ltd (+35.3%)
Phaos Technology closed up 35.3% at $3.14 on 10.8 million shares versus a 20-day average of 7.0 million. Market cap is $4.7M. It gapped up 12.1% at the open. The stock was also in our Nov. 12 top movers recap.
No news, filing or announcement explains the move. On Nov. 18 the company responded to unusual market activity, saying it knows of no undisclosed information explaining the trading. It also filed a 20-F/A that day, and coverage noted it expects to need more funding after a S$10.9M operating cash outflow. The move looks momentum-driven.
Technically there is no tracked pattern signal. RSI is 63, ADX is 37 (a strong trend), and the MA stack is mixed. The stock remains 97.2% below its 52-week high. RS rating is 95, but conviction is 4/100 (grade D) and trend-template is 3.
Free float is 52.9% and short-volume was 50%. A tiny market cap and a history of unexplained spikes make this very hard to trade.
GNLN — Greenlane Holdings, Inc. (+24.8%)
Greenlane closed up 24.8% at $0.75 on 12.2 million shares, about 19 times its 20-day average of 631,000. Market cap is just $529K. It gapped up 25.4% at the open.
No news from Nov. 19 explains the move. The latest items are from Nov. 16: Q3 net income of $4.4 million with lower liabilities, alongside a going-concern warning, and a change of audit chair. Coverage also notes expanded BERA treasury holdings. Nothing connects those items to today's jump, so it looks momentum-driven.
Technically there is no pattern signal. RSI is 25 (oversold), ADX is 36, and the MA stack is bearish. The stock is 97.3% below its 52-week high. RS rating is 1, conviction 36/100 (grade D), trend-template 0.
Free float is 100% and short-volume was 28%, so there is no low-float squeeze setup. A bounce from deeply oversold levels in a sub-$1 stock can fade fast.
The bottom line
Today's biggest gainers are mostly micro-caps with going-concern warnings, dilution or no clear catalyst. Big one-day moves often give much of the gain back, and none of these results imply the move continues. Patterns and squeezes fail often, so size positions small, set stops and do your own research. This is educational content, not financial advice.
StockSetups scans the full US universe after every close and every premarket morning. Use it to see which setups hold up once the hype fades.
Frequently asked questions
Why is SEAT up today?
Vivid Seats announced a debt recapitalization on Nov. 19. About $273 million of secured debt would be swapped for roughly 45.8 million new Class A shares, cutting net debt by about $232 million. Existing holders would be heavily diluted. The stock closed up 63.3% at $2.09.
Why is MRKR up today?
Marker Therapeutics reported a $16.2 million CPRIT grant on Nov. 19 to advance MT-601 into Phase 2. No source confirms it caused the 54.7% move, so that link is an inference.
What is a low-float short squeeze?
Low float means few shares are available to trade. If heavy buying meets heavy short selling, shorts may have to buy back shares, pushing price up sharply. Moves like this often reverse quickly.
Are the biggest stock gainers today good buys?
Not necessarily. Most are small, volatile and often diluted or unexplained moves. Chasing extended gainers is high-risk. This recap is educational, not advice.
Produced with AI assistance and published under the StockSetups editorial guidelines.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy